ES2584247T3 - Gen TOM34 relacionado con el cáncer de colon - Google Patents

Gen TOM34 relacionado con el cáncer de colon Download PDF

Info

Publication number
ES2584247T3
ES2584247T3 ES06781857.5T ES06781857T ES2584247T3 ES 2584247 T3 ES2584247 T3 ES 2584247T3 ES 06781857 T ES06781857 T ES 06781857T ES 2584247 T3 ES2584247 T3 ES 2584247T3
Authority
ES
Spain
Prior art keywords
tom34
cells
gene
protein
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06781857.5T
Other languages
English (en)
Spanish (es)
Inventor
Yusuke Nakamura
Yoichi Furukawa
Hideaki Tahara
Takuya Tsunoda
Satoshi Matsushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of ES2584247T3 publication Critical patent/ES2584247T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES06781857.5T 2005-07-27 2006-07-21 Gen TOM34 relacionado con el cáncer de colon Active ES2584247T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70326505P 2005-07-27 2005-07-27
US703265P 2005-07-27
PCT/JP2006/314947 WO2007013576A1 (en) 2005-07-27 2006-07-21 Colon cancer related gene tom34

Publications (1)

Publication Number Publication Date
ES2584247T3 true ES2584247T3 (es) 2016-09-26

Family

ID=37499354

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06781857.5T Active ES2584247T3 (es) 2005-07-27 2006-07-21 Gen TOM34 relacionado con el cáncer de colon

Country Status (18)

Country Link
US (1) US8674059B2 (https=)
EP (1) EP1910839B1 (https=)
JP (2) JP5095603B2 (https=)
KR (2) KR101325194B1 (https=)
CN (1) CN101278196B (https=)
AU (1) AU2006273192B2 (https=)
BR (1) BRPI0613970B8 (https=)
CA (1) CA2616497C (https=)
CY (1) CY1117839T1 (https=)
DK (1) DK1910839T3 (https=)
ES (1) ES2584247T3 (https=)
HU (1) HUE027330T2 (https=)
PL (1) PL1910839T3 (https=)
PT (1) PT1910839T (https=)
RU (2) RU2449020C2 (https=)
SG (1) SG163614A1 (https=)
SI (1) SI1910839T1 (https=)
WO (1) WO2007013576A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102439147A (zh) * 2009-03-04 2012-05-02 肿瘤疗法科学股份有限公司 Vangl1肽及包含它们的疫苗
TWI485245B (zh) * 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
TW201211250A (en) * 2010-09-07 2012-03-16 Oncotherapy Science Inc VANGL1 peptides and vaccines including the same
SG190407A1 (en) * 2010-12-02 2013-06-28 Oncotherapy Science Inc Tomm34 peptides and vaccines including the same
KR102127211B1 (ko) 2011-10-28 2020-06-29 온코세라피 사이언스 가부시키가이샤 Ｔｏｐｋ 펩티드 및 이를 포함하는 백신
SG11201405578TA (en) 2012-03-09 2014-11-27 Oncotherapy Science Inc Pharmaceutical composition containing peptide
EP3187191B1 (en) * 2014-08-26 2020-04-08 NKMAX Co., Ltd. Antibody for recognizing specific motif of wls protein, and pharmaceutical composition containing same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5785973A (en) * 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
JPH04504416A (ja) * 1989-02-17 1992-08-06 コセルコ・ミモトープス・ピィ・ティ・ワイ．エル・ティ・ディ． ペプチドの使用方法と合成方法
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
US20030198642A1 (en) 1995-08-03 2003-10-23 Johannes J. Geuze Cell derived antigen presenting vesicles
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
EP0960204A4 (en) 1996-07-26 2002-01-23 Sloan Kettering Inst Cancer METHODS AND REAGENTS FOR GENETIC IMMUNIZATION
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US7166573B1 (en) * 1999-05-28 2007-01-23 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
EP1250145A4 (en) 2000-01-03 2003-03-26 Argonex Pharmaceuticals Inc PEPTIDES DERIVED FROM ONCOGENE C-SKI FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
US20040181344A1 (en) * 2002-01-29 2004-09-16 Massachusetts Institute Of Technology Systems and methods for providing diagnostic services
TW200413406A (en) 2002-08-26 2004-08-01 Kirin Brewery Peptides and drugs containing the same
PT1581812E (pt) 2003-01-06 2008-09-22 Wyeth Corp Composições e métodos para diagnóstico e tratamento de cancros do cólon

Also Published As

Publication number Publication date
KR20080040738A (ko) 2008-05-08
JP5095603B2 (ja) 2012-12-12
KR20130087639A (ko) 2013-08-06
US8674059B2 (en) 2014-03-18
HK1115193A1 (zh) 2008-11-21
SG163614A1 (en) 2010-08-30
BRPI0613970B1 (pt) 2019-10-29
SI1910839T1 (sl) 2016-06-30
CN101278196A (zh) 2008-10-01
JP2012125248A (ja) 2012-07-05
RU2008107318A (ru) 2009-09-10
EP1910839B1 (en) 2016-04-27
WO2007013576A1 (en) 2007-02-01
KR101325194B1 (ko) 2013-11-06
AU2006273192B2 (en) 2011-09-01
CA2616497C (en) 2016-06-07
AU2006273192A1 (en) 2007-02-01
CN101278196B (zh) 2013-05-15
EP1910839A1 (en) 2008-04-16
BRPI0613970B8 (pt) 2021-05-25
RU2449020C2 (ru) 2012-04-27
BRPI0613970A2 (pt) 2011-02-22
HUE027330T2 (en) 2016-09-28
US20090214571A1 (en) 2009-08-27
RU2011127868A (ru) 2013-01-20
PL1910839T3 (pl) 2016-11-30
RU2526196C2 (ru) 2014-08-20
CA2616497A1 (en) 2007-02-01
CY1117839T1 (el) 2017-05-17
DK1910839T3 (en) 2016-07-04
JP2009502732A (ja) 2009-01-29
PT1910839T (pt) 2016-07-14

Similar Documents

Publication Publication Date Title
Wei et al. M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942
US8513194B2 (en) Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
US8067473B2 (en) Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors
Javid et al. The role of heat shock proteins in metastatic colorectal cancer: A review
ES2909961T3 (es) Biomarcadores de células senescentes
Lee et al. Differential gene expression profiles of radioresistant non–small-cell lung cancer cell lines established by fractionated irradiation: Tumor protein p53-inducible protein 3 confers sensitivity to ionizing radiation
WO2017067454A1 (zh) Lsd1抑制剂用于防治三阴性乳腺癌的医药用途和药物产品
Liu et al. Ciz1 promotes tumorigenicity of prostate carcinoma cells
EP2641610A2 (en) Anticancer composition containing gkn 1
ES2584247T3 (es) Gen TOM34 relacionado con el cáncer de colon
US20100092456A1 (en) Methods of treatment
JP4851451B2 (ja) 乳癌関連遺伝子ｚｎｆｎ３ａ１
JP2009505632A (ja) 膵臓癌関連遺伝子であるｃｓｔ６およびｇａｂｒｐ
US20110039789A1 (en) Use of Huntingtin Protein for the Diagnosis and the Treatment of Cancer
US20070054259A1 (en) Modulation of hnRNP H and treatment of DM1
US9808506B2 (en) Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof
ES2364078T3 (es) Gen y polipéptido relacionados con el cáncer de mama.
JP2012501166A (ja) 乳癌関連遺伝子ｒｑｃｄ１
ES2524246T3 (es) Moduladores de la actividad ubiquitinasa Itch
CN107723369A (zh) Setd1b蛋白及其编码基因在肝癌诊断治疗中的应用
US9464291B2 (en) Methods and compositions for the treatment of cancer
CN121588147A (zh) Tpra1在溶瘤病毒抗肿瘤效应中的应用
Sanzey et al. 277 Identification of Novel Therapeutic Targets Through an Integrated in Vitro and in Vivo Whole Genome ShRNA Screen in Glioma Stem Cells
Bagley et al. 62 Isolation of pericytes from vasculature of human lung tumors
HK1115193B (en) Colon cancer related gene tom34